JohnnyVodka
Bluelighter
- Joined
- May 29, 2010
- Messages
- 948
Not had any 'brain zaps', despite doing 500mg last weekend.
Well, as a caveat, we can't really narrow down the negative after-effects of MDMA to depletion of serotonin alone. However, MDAI has a few advantages over MDMA, which make the former a bit less likely to cause negative after-effects:
1. There is no concurrent release of dopamine, meaning that there will be reduced oxidative stress (at DA and 5ht neurons).
2. Due to its cylcization, MDAI doesn't form the same toxic metabolites that MDMA does.
3. MDAI doesn't inhibit tryptophan hydroxylase as MDMA does.
However, MDAI is not magic; if used in doses a few times the active 150 mg or a few days in a row, you very likely will experience negative after-effects.
ebola
Yes, MDMA is a reuptake inhibitor (though it's much stronger as a releaser); It's very rare for a releaser to not also act as a reuptake inhibitor.
Everyone plz take a second and think about it, if a drug puts a transporter in reverse how is it ganne reuptake into the cell.
Can I restate with WHILE the chemical is bound to the transporter protein it will be a releasing agent and hense also inhibit the reuptake. What timing there?
I bought white crystalline 'mdai' and it was not mdai. It tested completely differently with Marquis.
Table 1
WSa Label Comment
1 NRG-1 - Butylone + MDPV
2 NRG-1 - Flephedrone (4-fluoromethcathinone)
3 NRG-1 - Flephedrone + MDPV
3 NRG-2 - 4-Methyl-N-ethylcathinone
4 NRG-1 - Flephedrone + MDPV
5 NRG-1 - Caffeine + traces of mephedrone
6 NRG-1 - Naphyrone
7 NRG-1 - Butylone + MDPV
8 MDAI - Inorganic composition
9 NRG-1 - Mephedrone
10 NRG-1 - Inorganic composition
10 NRG-2 - Mephedrone + benzocaine
11 NRG-1 - Mephedrone
11 NRG-2 - Mephedrone
11 DMC - Caffeine + lidocaine
11 MDAI - Mephedrone
12 NRG-2 - 4-Methyl-N-ethylcathinone